Results of an antimicrobial stewardship program

Not Applicable

• Conditions: Infectious diseases; Communicable Diseases; Infection; Environmental Illness

• Registration Number: RPCEC00000275
• Lead Sponsor: Pharmaceutical Promotion and Prevention Research Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-05-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 514

Inclusion Criteria

1. Patient older than 18 years.
2. Patients who, within their pharmacotherapy, have a minimum prescribed one of the following antibiotics:
• Penicillins: Piperacillin / Tazobactam.
• Cephalosporins: Ceftriaxone, Ceftazidime, Cefepime, Ceftaroline.
• Carbapenems: Meropenem, Doripenem, Imipenem / Cilastatin, Ertapenem.
• Quinolones: Ciprofloxacin.
• Glycopeptides: Vancomycin.
• Polymyxins: Polymyxin B, Colistin
• Oxazolidinones: Linezolid.
• Cyclic lipopeptides: Daptomycin.
• Tetracyclines: Tigecycline.

Exclusion Criteria

1. Patients without the first evaluation by the treating medical specialty.
2. Patients receiving extracorporeal membrane oxygenation (ECMO).
3. Patients with cystic fibrosis. and. Administration of antimicrobials subcutaneously, intraperitoneally or intrathecally.
4. Patients admitted to surgery and hemodynamics.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Consumption of carbapenemic antimicrobials (The Defined Daily Dose will be used as a mean daily dose when a drug (antibiotic) is used in its main indication in adults. In this case, the daily dose defined by 100 patient-days will be calculated, using the formula DDD/100 patients-day = g Antimicrobial x (100 / DDD specific (g) n ° days x n ° patients)). Measurement time: at the end of antibiotic treatment.

Secondary Outcome Measures

Name	Time	Method
Duration of antibiotic treatment (It will be measure in Days). Measurement time: at the end of antibiotic treatment. <br>Costs associated with antibiotic treatment (It will be measure in American dollars). Measurement time: at the end of antibiotic treatment.